BIDU vs META
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Baidu's financial health is strong with a Piotroski F-Score of 7/9, indicating solid operational performance and balance sheet strength. However, the lack of an Altman Z-Score prevents a full distress risk assessment, while declining revenue and earnings growth raise concerns about future momentum. Despite a current price of $161.44 trading near its Graham Number of $167.2, the stock shows mixed signals with weak profitability metrics like ROE (3.08%) and low profit margins (6.90%) relative to sector peers. Analysts maintain a 'buy' recommendation with a target of $171.54, supported by recent earnings beat trends, though decelerating fundamentals and bearish technicals temper near-term optimism.
META exhibits exceptional fundamental health with a Piotroski F-Score of 8/9, indicating strong financial strength across profitability, leverage, and operating efficiency. While the current price of $612.42 trades at a premium to the Graham Number ($213.17) and the growth-based Intrinsic Value ($542.14), the PEG ratio of 0.94 suggests the stock is undervalued relative to its high growth rate. Strong revenue growth (23.8%) and a low forward P/E (17.03) outweigh the bearish technical trend and insider selling. The company's dominant market position and consistent earnings beats support a bullish long-term outlook.
Compare Another Pair
Related Comparisons
BIDU vs META: Head-to-Head Comparison
This page compares Baidu, Inc. (BIDU) and Meta Platforms, Inc. (META) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.